Emma K Benn, DrPH Email Emma Benn
-
- Position
- ASSISTANT PROFESSOR | Population Health Science and Policy
-
- Language
- English
Emma K. T. Benn, MPH, DrPH is an Assistant Professor in the Center for Biostatistics and Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai. She received her BA in Chemistry (Spanish Minor) in 2004 from Swarthmore College. She subsequently received her MPH in Sociomedical Sciences in 2007 and DrPH in Biostatistics in 2012 from the Columbia University Mailman School of Public Health. Dr. Benn is one of the co-founders of the NIH-funded Biostatistics Enrichment Summer Training (BEST) Diversity Program in the Department of Biostatistics at Mailman. She has contributed her biostatistical expertise to a variety of research areas including: epilepsy, traumatic brain injury, COPD, prostate cancer, bladder cancer, HPV, skin bleaching in African and Afro-Caribbean populations, stroke, and cognitive disability. More recently, Dr. Benn has been focused on causal inference in disparities research and applying econometrics-related methods to account for selectivity bias in clinical and translational research.
Follow Dr. Benn on Twitter @EKTBenn along with our Center for Biostatistics @SinaiBiostats.
Education
BA, Swarthmore College
MPH, Columbia University Mailman School of Public Health
DrPH, Columbia University Mailman School of Public Health
Language
English
2013-2015 NIH/NIMHD Loan Repayment Program for Health Disparities Research Recipient
2014 Women in Statistics Junior Researcher Travel Award
2014 Joint Statistical Meetings (JSM) Diversity Mentoring Program Fellow
The Applied Statistics in Biological Systems (ASIBS) Short Course
NIH/NIGMS R25GM111239 (Role - Co-PI; Project Duration - 2015 to 2020)
2015 Beta Omicron Chapter Inductee of the Delta Omega Honorary Society in Public Health
Icahn School of Medicine at Mount Sinai
Benn EK. Nativity and cognitive disability among children: a unique comparison with reduced selection bias. International journal of public health 2014 Jun; DOI: 10.1007/s00038-014-0571-9.
Hart T, Benn EK, Bagiella E, Arenth P, Dikmen S, Hesdorffer DC, Novack TA, Ricker JH, Zafonte R. Early Trajectory of Psychiatric Symptoms after Traumatic Brain Injury: Relationship to Patient and Injury Characteristics. Journal of neurotrauma 2014 April; 31(7): 610-617.
Epstein LG, Shinnar S, Hesdorffer DC, Nordli DR, Hamidullah A, Benn EK, Pellock JM, Frank LM, Lewis DV, Moshe SL, Shinnar RC, Sun S. Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study. Epilepsia 2012 Sep; 53(9): 1481-1488.
Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, Walczak TS, Beghi E, Brodie MJ, Hauser WA. Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia 2012 Feb; 53(2): 249-252.
Leaffer EB, Jacoby A, Benn E, Hauser WA, Shih T, Dayan P, Green R, Andrews H, Thurman DJ, Hesdorffer D. Associates of stigma in an incident epilepsy population from northern Manhattan, New York City. Epilepsy & behavior : E&B 2011 May; 21(1): 60-64.
Hesdorffer DC, Benn EK, Bagiella E, Nordli D, Pellock J, Hinton V, Shinnar S. Distribution of febrile seizure duration and associations with development. Annals of neurology 2011 Jul; 70(1): 93-100.
Hesdorffer DC, Logroscino G, Benn EK, Katri N, Cascino G, Hauser WA. Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology 2011 Jan; 76(1): 23-27.
Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, Walczak TS, Beghi E, Brodie MJ, Hauser A. Combined analysis of risk factors for SUDEP. Epilepsia 2011 Jun; 52(6): 1150-1159.
Perucca P, Jacoby A, Marson AG, Baker GA, Lane S, Benn EK, Thurman DJ, Hauser WA, Gilliam FG, Hesdorffer DC. Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology 2011 Jan; 76(3): 273-279.
Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E. Incidence of amyotrophic lateral sclerosis in Europe. Journal of neurology, neurosurgery, and psychiatry 2010 Apr; 81(4): 385-390.
Benn EK, Hesdorffer DC, Levy SR, Testa FM, Dimario FJ, Berg AT. Parental report of behavioral and cognitive diagnoses in childhood-onset epilepsy: A case-sibling-controlled analysis. Epilepsy & behavior : E&B 2010 Jul; 18(3): 276-279.
Westhoff CL, Torgal AH, Mayeda ER, Stanczyk FZ, Lerner JP, Benn EK, Paik M. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstetrics and gynecology 2010 Aug; 116(2 Pt 1): 275-283.
Hesdorffer DC, Benn EK, Cascino GD, Hauser WA. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 2009 May; 50(5): 1102-1108.
Benn EK, Hauser WA, Shih T, Leary L, Bagiella E, Dayan P, Green R, Andrews H, Thurman DJ, Hesdorffer DC. Underlying cause of death in incident unprovoked seizures in the urban community of Northern Manhattan, New York City. Epilepsia 2009 Oct; 50(10): 2296-2300.
Lederer DJ, Benn EK, Barr RG, Wilt JS, Reilly G, Sonett JR, Arcasoy SM, Kawut SM. Racial differences in waiting list outcomes in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 2008 Feb; 177(4): 450-454.
Benn EK, Hauser WA, Shih T, Leary L, Bagiella E, Dayan P, Green R, Andrews H, Thurman DJ, Hesdorffer DC. Estimating the incidence of first unprovoked seizure and newly diagnosed epilepsy in the low-income urban community of Northern Manhattan, New York City. Epilepsia 2008 Aug; 49(8): 1431-1439.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Benn did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.